Latest Financials News

Redivium Limited confirms a setback in securing its Wrexham recycling plant lease but maintains strong project fundamentals and explores innovative refining technology to boost UK battery material production.

Redivium Limited is advancing a recapitalisation strategy with Australian investors to meet ASX requirements and resume trading after a prolonged suspension.

Prophecy International Holdings and Complexica have mutually terminated their planned all-scrip merger, prompting Prophecy to cancel its intended $1.5 million on-market share buy-back.

Atlantic Lithium has secured £3 million through two share placements with Long State Investments, issuing new warrants and security shares to strengthen its financial footing ahead of Ghana's first lithium mine development.

National Storage REIT has received a conditional, non-binding proposal from a Brookfield and GIC consortium to acquire all stapled securities at $2.86 each, triggering an exclusivity period for negotiations.

Sports Entertainment Group (SEG) reported a 62% jump in underlying EBITDA for FY25, underpinned by strong margin expansion and operational leverage. The company reaffirms its optimistic FY26 outlook with double-digit EBITDA growth expected.

Airtasker Limited showcased strong FY25 financials and unveiled aggressive growth plans in the UK and US, supported by strategic media partnerships and core platform investments.

Sports Entertainment Group Limited (SEG) reports a robust start to FY26 with a 63% jump in underlying EBITDA and advances its strategic exit from Perth Wildcats.

ECP Emerging Growth Limited reported a modest 2.4% return for FY2025, lagging the ASX Small Ordinaries Index, but is pursuing new strategies including a pre-IPO fund investment and a special dividend to address shareholder value concerns.

MotorCycle Holdings Limited delivered a standout FY2025 with double-digit revenue and profit growth, underpinned by strong market share gains and operational efficiencies.

MotorCycle Holdings Limited reported a robust 2025 financial year with record revenue and profit growth, strengthened by key acquisitions that expanded its market share to 22%. The company’s focus on operational efficiency and digital transformation sets the stage for continued momentum in 2026.

Anatara Lifesciences has completed the final tranche of its placement, issuing over 66 million shares and granting options to its lead manager, marking a key step in its capital raising strategy.